Parallax Volatility Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$939K Sell
15,000
-5,800
-28% -$404K ﹤0.01% 935
2025
Q4
$1.38M Sell
20,800
-19,200
-48% -$1.24M ﹤0.01% 1037
2025
Q3
$2.69M Buy
40,000
+25,000
+167% +$1.98M ﹤0.01% 836
2025
Q2
$1.31M Hold
15,000
﹤0.01% 1000
2025
Q1
$1.02M Buy
15,000
+6,800
+83% +$555K ﹤0.01% 1038
2024
Q4
$638K Sell
8,200
-92,000
-92% -$6.81M ﹤0.01% 1454
2024
Q3
$6.72M Buy
100,200
+17,700
+21% +$1.45M 0.01% 686
2024
Q2
$9.35M Buy
82,500
+38,600
+88% +$4.88M 0.02% 502
2024
Q1
$6.09M Sell
43,900
-151,300
-78% -$19M 0.01% 661
2023
Q4
$24.2M Sell
195,200
-4,900
-2% -$501K 0.05% 338
2023
Q3
$18.7M Buy
200,100
+81,600
+69% +$9.2M 0.04% 350
2023
Q2
$15.2M Buy
118,500
+23,800
+25% +$2.88M 0.03% 417
2023
Q1
$11M Sell
94,700
-112,600
-54% -$12.6M 0.02% 553
2022
Q4
$23.5M Buy
207,300
+69,400
+50% +$7.62M 0.04% 476
2022
Q3
$11.1M Buy
137,900
+32,000
+30% +$2.71M 0.02% 733
2022
Q2
$7.89M Sell
105,900
-32,100
-23% -$2.93M 0.01% 816
2022
Q1
$17.6M Buy
+138,000
New +$15.1M 0.01% 557
2020
Q4
Sell
-982,400
Closed -$101M 2826
2020
Q3
$101M Buy
982,400
+478,400
+95% +$50M 0.08% 228
2020
Q2
$51.1M Buy
504,000
+188,000
+59% +$16.8M 0.06% 257
2020
Q1
$21.3M Buy
+316,000
New +$19.7M 0.03% 397
2018
Q1
Sell
-80,000
Closed -$1.15M 2650
2017
Q4
$1.15M Buy
+80,000
New +$1.04M ﹤0.01% 1135

Other funds holding DXCM

Parallax Volatility Advisers's DXCM Position: Q1 2026 in Review

Parallax Volatility Advisers increased its DexCom (DXCM) stake by 360% in Q1 2026, buying an estimated $480K and bringing the position to 8,802 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Parallax Volatility Advisers first reported a position in DXCM in Q1 2017 and has held it in 21 quarters since. The position peaked at $12M in Q3 2020. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Parallax Volatility Advisers held 8,802 shares of DexCom worth $551K as of Q1 2026.
  • Parallax Volatility Advisers bought 6,888 DexCom shares in Q1 2026, an estimated $480K.
  • DexCom made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1046 holding.
  • Parallax Volatility Advisers first reported a position in DexCom in Q1 2017 and has held it in 21 quarters since.
  • Parallax Volatility Advisers's DexCom position peaked at $12M in Q3 2020.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.